Thu, July 28, 2011
[ Thu, Jul 28th 2011 ]: Market Wire
POZEN Reports Second Quarter 2011 Results
[ Thu, Jul 28th 2011 ]: Market Wire
Amedisys Home Health Care Receives Pay-for-Performance Award from CMS
[ Thu, Jul 28th 2011 ]: Market Wire
GTx, Inc. To Host Second Quarter 2011 Financial Results Conference Call and Webcast
[ Thu, Jul 28th 2011 ]: Market Wire
Incyte Reports Second Quarter 2011 Financial Results and Provides Update on Key Clinical Programs
[ Thu, Jul 28th 2011 ]: Market Wire
Natus Medical Announces 2011 Second Quarter Financial Results
[ Thu, Jul 28th 2011 ]: Market Wire
Spectranetics Achieves Record Revenue of $32.2 Mi .. lion in Second Quarter, 7% Growth over Prior Year
Wed, July 27, 2011
[ Wed, Jul 27th 2011 ]: Market Wire
Dr. Reddya?s Announces the Launch of Gemcitabine for Injection
[ Wed, Jul 27th 2011 ]: Market Wire
Electromed, Inc. Presents Distinguished Service Award to Jerry Cahill
[ Wed, Jul 27th 2011 ]: Market Wire
Aetna Joins Effort to Increase Disability Awareness, Planning and Prevention
[ Wed, Jul 27th 2011 ]: Market Wire
U.S. Physical Therapy Makes 20 Clinic Acquisition
[ Wed, Jul 27th 2011 ]: Market Wire
CytRx Prices $20.4 Million Public Offering
[ Wed, Jul 27th 2011 ]: Market Wire
Affymax and Takeda Announce FDA Acceptance of New Drug Application for Peginesatide
[ Wed, Jul 27th 2011 ]: Market Wire
POZEN Welcomes Dr. Seth A. Rudnick to the Board of Directors
[ Wed, Jul 27th 2011 ]: Market Wire
Repligen Reports First Quarter Fiscal Year 2012 Financial Results
[ Wed, Jul 27th 2011 ]: Market Wire
Positive Data Demonstrating dermaPACE Safely Heal .. Highlighted in CME Presentation at the American P
[ Wed, Jul 27th 2011 ]: Market Wire
Columbia Laboratories Licenses STRIANT Canadian T .. Marketing Rights to Invaron Pharmaceuticals Inc.
[ Wed, Jul 27th 2011 ]: Market Wire
Illumina to Present at Leerink Swann Life Science Tools and Diagnostics Roundtable
Tue, July 26, 2011
[ Tue, Jul 26th 2011 ]: Market Wire
Biogen Idec en Swedish Orphan Biovitrum presenter .. et langdurig werkzame recombinante factor VIII ti
[ Tue, Jul 26th 2011 ]: Market Wire
Merck to Acquire Rights to Vernakalant i.v. in Canada, Mexico and the United States from Astellas
[ Tue, Jul 26th 2011 ]: Market Wire
Interim Data from Phase 2 Study of Combination Re .. CIVEKa" Suggest Potential to Treat Genotype 1 Hep
[ Tue, Jul 26th 2011 ]: Market Wire
Ligand Partner GlaxoSmithKline Receives Positive .. LE1 Study in Hepatitis C-Related Thrombocytopenia
[ Tue, Jul 26th 2011 ]: Market Wire
Biogen Idec Reports Second Quarter 2011 Results
[ Tue, Jul 26th 2011 ]: Market Wire
Biogen Idec y Swedish Orphan Biovitrum presentan .. factor VIII recombinante con accin duradera en la
[ Tue, Jul 26th 2011 ]: Market Wire
American Anesthesiology Announces the Acquisition of Group Practice Based in Palm Beach County, FL
[ Tue, Jul 26th 2011 ]: Market Wire
Dyax Corp. and Kadmon Corporation Announce Antibody Library License Agreement
[ Tue, Jul 26th 2011 ]: Market Wire
Arrowhead Research Announces Oncology Expert Timo .. Triche to Join Calando Scientific Advisory Board
[ Tue, Jul 26th 2011 ]: Market Wire
Biogen Idec et Swedish Orphan Biovitrum pr©sente .. ement avec le facteur VIII recombinant action pro
[ Tue, Jul 26th 2011 ]: Market Wire
Biogen Idec und Swedish Orphan Biovitrum legen Da .. wirkenden rekombinanten Faktor VIII auf der Tagun
Mon, July 25, 2011
[ Mon, Jul 25th 2011 ]: Market Wire
Biogen Idec erhlt bedingte Marktzulassung fr FAMP .. zur Verbesserung der Gehfhigkeit erwachsener Mul
[ Mon, Jul 25th 2011 ]: Market Wire
Threshold Pharmaceuticals Announces Initiation of .. -302 in Combination with Bevacizumab at Universit
[ Mon, Jul 25th 2011 ]: Market Wire
Response Genetics Announces Search for New CEO
[ Mon, Jul 25th 2011 ]: Market Wire
Celldex Therapeutics to Report Second Quarter 201 .. ts and Host Corporate 2011 Objectives Update Call
[ Mon, Jul 25th 2011 ]: Market Wire
Alnylam and MIT Collaborators Discover Novel aCor .. ticles for Systemic Delivery of RNAi Therapeutics
[ Mon, Jul 25th 2011 ]: Market Wire
Amyris Commissions Commercial Production Operations at Antibiticos
[ Mon, Jul 25th 2011 ]: Market Wire
Amyris and Firmenich Announce Expansion of Collaboration
[ Mon, Jul 25th 2011 ]: Market Wire
Amyris pronta para produo comercial na Antibiticos
[ Mon, Jul 25th 2011 ]: Market Wire
Amyris e Firmenich anunciam expanso de colaborao
[ Mon, Jul 25th 2011 ]: Market Wire
Illumina Announces First Customer Shipments of the Omni5 BeadChip
[ Mon, Jul 25th 2011 ]: Market Wire
Acorda Therapeutics to Host Conference Call to Di .. Quarter 2011 Financial Results on August 1, 2011
Sat, July 23, 2011
[ Sat, Jul 23rd 2011 ]: Market Wire
Mettler-Toledo International Inc. to Webcast Investor Presentation
Fri, July 22, 2011
[ Fri, Jul 22nd 2011 ]: Market Wire
Watson Confirms JALYNa" Patent Challenge
[ Fri, Jul 22nd 2011 ]: Market Wire
Electromed, Inc. Names Diane M. Erdman as HR Director
[ Fri, Jul 22nd 2011 ]: Market Wire
30 p.m. ET to Discuss Financial Results for the Second Quarter and Six Months Ended June 30, 2011
[ Fri, Jul 22nd 2011 ]: Market Wire
Dr. Reddya?s Acquires Prescription Business of JB .. s & Pharmaceuticals in Russia & Other CIS Markets
[ Fri, Jul 22nd 2011 ]: Market Wire
International Drug & Explosives Detection Company .. From India for Drug Detectors and Explosive Ident
[ Fri, Jul 22nd 2011 ]: Market Wire
Centric Health to Acquire Majority Interest in Performance Medical Group
Thu, July 21, 2011
[ Thu, Jul 21st 2011 ]: Market Wire
Nephros Receives 510k Approval to Market Additional Ultrafiltration Products
[ Thu, Jul 21st 2011 ]: Market Wire
Sunrise to Host Conference Call and Webcast to Discuss Second-Quarter 2011 Financial Results

Biogen Idec en Swedish Orphan Biovitrum presenteren gegevens van behandeling met langdurig werkzame recombinante factor VIII ti

KYOTO, Japan--([ BUSINESS WIRE ])--Biogen Idec (NASDAQ: BIIB) en Swedish Orphan Biovitrum (STO: SOBI) maken vandaag testgegevens bekend uit een fase 1/2a, waaruit blijkt dat het langdurig werkzame fusieprotene met factor VIII Fc (rFVIIIFc) goed verdragen werd door 16 eerder behandelde patinten met zware hemofilie A en dat het een halfwaardetijd heeft die ongeveer 1,7 langer is in vergelijking met Advate (recombinante stollingsfactor, plasma/albumine-vrije methode, rFVIII). Vandaag worden deze gegevens gepresenteerd tijdens het XXIIIde congres van de International Society on Thrombosis and Haemostasis in Kyoto, Japan.

Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen zijn slechts als leeshulp bedoeld en moeten worden vergeleken met de tekst in de brontaal welke als enige juridische geldigheid beoogt.